CA2013166A1 - Suppression de la synthese et de la secretion de l'hormone parathyroide - Google Patents
Suppression de la synthese et de la secretion de l'hormone parathyroideInfo
- Publication number
- CA2013166A1 CA2013166A1 CA2013166A CA2013166A CA2013166A1 CA 2013166 A1 CA2013166 A1 CA 2013166A1 CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A1 CA2013166 A1 CA 2013166A1
- Authority
- CA
- Canada
- Prior art keywords
- secretion
- suppression
- parathyroid hormone
- hormone synthesis
- hyperparathyroidism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 229960001319 parathyroid hormone Drugs 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 201000002980 Hyperparathyroidism Diseases 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 150000003704 vitamin D3 derivatives Chemical class 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/329,606 US4948789A (en) | 1989-03-28 | 1989-03-28 | Suppression of parathyroid hormone synthesis and secretion |
| US329,606 | 1989-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2013166A1 true CA2013166A1 (fr) | 1990-09-28 |
| CA2013166C CA2013166C (fr) | 2001-01-02 |
Family
ID=23286199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002013166A Expired - Lifetime CA2013166C (fr) | 1989-03-28 | 1990-03-27 | Suppression de la synthese et de la secretion de l'hormone parathyroide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4948789A (fr) |
| EP (1) | EP0390114B1 (fr) |
| JP (1) | JPH0686382B2 (fr) |
| KR (1) | KR0153532B1 (fr) |
| AT (1) | ATE111737T1 (fr) |
| AU (1) | AU618506B2 (fr) |
| CA (1) | CA2013166C (fr) |
| DE (1) | DE69012620T2 (fr) |
| DK (1) | DK0390114T3 (fr) |
| ES (1) | ES2063852T3 (fr) |
| HK (1) | HK66895A (fr) |
| HU (1) | HU211597A9 (fr) |
| IE (1) | IE64949B1 (fr) |
| IL (1) | IL93896A (fr) |
| ZA (1) | ZA902353B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5063221A (en) * | 1989-04-05 | 1991-11-05 | Chugai Seiyaku Kabushiki Kaisha | Treatment for hyperparathyroidism with use of vitamin d derivatives |
| GB9017890D0 (en) | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| GB9220272D0 (en) * | 1992-09-25 | 1992-11-11 | Leo Pharm Prod Ltd | Chemical compounds |
| US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
| US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
| US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
| US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| IL153378A0 (en) * | 2000-07-18 | 2003-07-06 | Bone Care Internat Inc | STABILIZED 1alpha-HYDROXY VITAMIN D |
| US20050101574A1 (en) * | 2000-08-30 | 2005-05-12 | Seiichi Ishizuka | Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
| US7129230B2 (en) | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
| US20040248859A1 (en) * | 2001-07-03 | 2004-12-09 | Michinori Hirata | Medicinal compositions for treating secondary parathyroid hyperfunction and remedies for cardiovascular complications in association with treatment for secondary parathyroid hyperfunction |
| US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
| US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
| US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
| US7094775B2 (en) | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1332841C (fr) * | 1984-11-27 | 1994-11-01 | Noboru Kubodera | Derives de vitamine d et procede de production |
| US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
-
1989
- 1989-03-28 US US07/329,606 patent/US4948789A/en not_active Expired - Lifetime
-
1990
- 1990-03-22 AU AU52106/90A patent/AU618506B2/en not_active Expired
- 1990-03-23 IE IE108390A patent/IE64949B1/en not_active IP Right Cessation
- 1990-03-26 IL IL9389690A patent/IL93896A/en not_active IP Right Cessation
- 1990-03-27 CA CA002013166A patent/CA2013166C/fr not_active Expired - Lifetime
- 1990-03-27 ZA ZA902353A patent/ZA902353B/xx unknown
- 1990-03-27 KR KR1019900004135A patent/KR0153532B1/ko not_active Expired - Fee Related
- 1990-03-28 DE DE69012620T patent/DE69012620T2/de not_active Expired - Lifetime
- 1990-03-28 AT AT90105922T patent/ATE111737T1/de not_active IP Right Cessation
- 1990-03-28 DK DK90105922.0T patent/DK0390114T3/da active
- 1990-03-28 EP EP90105922A patent/EP0390114B1/fr not_active Expired - Lifetime
- 1990-03-28 ES ES90105922T patent/ES2063852T3/es not_active Expired - Lifetime
- 1990-03-28 JP JP2080544A patent/JPH0686382B2/ja not_active Expired - Lifetime
-
1995
- 1995-05-04 HK HK66895A patent/HK66895A/en not_active IP Right Cessation
- 1995-06-30 HU HU95P/P00670P patent/HU211597A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU211597A9 (en) | 1995-12-28 |
| JPH037231A (ja) | 1991-01-14 |
| IE64949B1 (en) | 1995-09-20 |
| AU5210690A (en) | 1990-10-04 |
| US4948789A (en) | 1990-08-14 |
| HK66895A (en) | 1995-05-12 |
| DE69012620T2 (de) | 1995-03-23 |
| CA2013166C (fr) | 2001-01-02 |
| IL93896A (en) | 1994-10-21 |
| KR900013965A (ko) | 1990-10-22 |
| EP0390114B1 (fr) | 1994-09-21 |
| JPH0686382B2 (ja) | 1994-11-02 |
| ZA902353B (en) | 1990-12-28 |
| KR0153532B1 (ko) | 1998-11-16 |
| ES2063852T3 (es) | 1995-01-16 |
| AU618506B2 (en) | 1991-12-19 |
| IE901083L (en) | 1990-09-28 |
| ATE111737T1 (de) | 1994-10-15 |
| EP0390114A2 (fr) | 1990-10-03 |
| EP0390114A3 (fr) | 1991-10-30 |
| DK0390114T3 (da) | 1994-10-17 |
| DE69012620D1 (de) | 1994-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2013166A1 (fr) | Suppression de la synthese et de la secretion de l'hormone parathyroide | |
| MD960256A (en) | Substances, used as sweetening agents and process for preparation thereof | |
| AU1608692A (en) | Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants | |
| TW221293B (fr) | ||
| AU7484887A (en) | Method for inhibiting aging | |
| IL99775A0 (en) | Antimicrobial agents containing substituted 2-cyclohexan-1-yl-amino derivatives,certain such novel compounds and their preparation | |
| HU912649D0 (en) | New tricyclic compounds production threreof and anti-microbic preparatives | |
| GR1002573B (el) | Μικροβιακη μεθοδος παρασκευης μεβινολινης. | |
| PT83104B (en) | Novel guanidinomethylbenzoic acid derivatives | |
| EP0743308A3 (fr) | Composé quinazoléine et composition contre les tumeurs le contenant comme composé actif | |
| EP0186023A3 (fr) | Dérivés d'acides biliaires, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| HK10292A (en) | Intermediates for agriculturally useful acrylic acid derivatives | |
| ES8301928A1 (es) | Un procedimiento para preparar 4-(2-4-dicloro-3-metilbenzoil)-1,3-dimetil-5-fenaciloxipirazol). | |
| RU2091378C1 (en) | 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition | |
| GB8908700D0 (en) | Compounds | |
| ES8403911A1 (es) | Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0 | |
| HK47592A (en) | Piperazine derivatives | |
| PL314794A1 (en) | Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine | |
| JPS5775949A (en) | Lidocaine derivative and therapeutical composition containing same as effective ingredient | |
| IE822853L (en) | 1-piperazino carboxylates | |
| TW344650B (en) | Fungicidal compositions and the process for the preparation thereof | |
| GB2039739A (en) | Medicament against glaucoma | |
| HU9600606D0 (en) | Process for the preparation of indolizine derivatives | |
| HK47492A (en) | Piperazine derivatives | |
| HUT58471A (en) | Herbicidal composition comprising (sulfamidosulfonyl)-urea derivatives as active ingredient and process for producing the active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |